VRS-317

· Versartis Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VRS-317, covering 2012-07-23 to 2012-07-23. Get the full timeline:

Most recent: Clinical Trial Update: VRS-317 in Adult Subjects With Growth Hormone Deficiency [Phase 1]